Point-of-Care Diagnostics

On this page

POCD Fundamentals - Speedy Labside Tests

  • Diagnostic tests performed at or near patient site; "lab-on-a-chip" principle.
  • Aim: Rapid sample-to-answer, typically <30 minutes.
  • Benefits:
    • ↓ Turnaround Time (TAT).
    • Quicker diagnosis, faster treatment initiation.
    • Enhanced patient access, especially in remote/resource-limited settings.
    • Reduced sample transport needs & pre-analytical errors.
  • Examples: Glucometers, urine dipsticks, pregnancy tests, RDTs (malaria, HIV, dengue), cardiac troponin, D-dimer.
  • Challenges: Operator variability, rigorous Quality Control (QC) essential, cost per test, interpretation. POC Devices Characteristics and Examples

⭐ WHO's ASSURED criteria for ideal POCDs: Affordable, Sensitive, Specific, User-friendly, Rapid & Robust, Equipment-free, Deliverable. 📌

Enabling Technologies - Tiny Test Titans

  • Microfluidics ("Lab-on-a-Chip"):
    • Miniaturized fluid handling (µL to nL).
    • ↓ sample/reagent volumes, ↑ analysis speed, portability.
    • Integrates multiple lab functions on one chip.
  • Biosensors:
    • Combine biological recognition element (e.g., antibody, enzyme) with a physicochemical transducer.
    • Key types: Electrochemical (e.g., glucometers), Optical (colorimetric, fluorescent), Piezoelectric.
  • Nanotechnology:
    • Nanoparticles (e.g., gold) for signal amplification, enhancing sensitivity.
    • Quantum dots for multiplexed detection.
  • Lateral Flow Assays (LFAs):
    • Paper-based, user-friendly, rapid (results in 5-30 mins).
    • Widely used for qualitative/semi-quantitative detection.

    ⭐ LFAs are the most commercialized POCD tech (e.g., pregnancy tests, COVID-19 antigen tests) due to low cost & simplicity.

  • Smartphone Integration:
    • Utilizes camera for imaging/reading, processing power for analysis.
    • Enables connectivity for data management & telemedicine.

Salivary Biomarker Point-of-Care Microfluidic Detection

Clinical Impact - Bedside Breakthroughs

  • Infectious Diseases:
    • Rapid pathogen identification (e.g., Malaria RDTs, HIV, TB-LAMP, Dengue NS1, COVID-19 antigen).
    • Facilitates early treatment initiation & antimicrobial stewardship.
  • Cardiology:
    • Bedside cardiac biomarkers (e.g., Troponin I/T, NT-proBNP) for acute coronary syndrome (ACS) diagnosis.
    • D-dimer for venous thromboembolism (VTE) exclusion.
  • Endocrinology:
    • Blood glucose monitoring (glucometers, CGM).
    • Point-of-care HbA1c for diabetes management review.
  • Critical Care & Emergency Medicine:
    • Arterial blood gas (ABG), lactate, electrolytes for rapid assessment.
    • Coagulation status (e.g., INR, ACT) for urgent interventions.
  • Primary Care & Rural Health:
    • Improved screening for anemia, infections; chronic disease monitoring.
    • Reduces unnecessary referrals, enables timely care in remote settings.

⭐ Point-of-care C-Reactive Protein (CRP) testing aids in differentiating bacterial from viral infections, guiding prudent antibiotic prescribing in primary care, especially for respiratory tract infections. Blood draw for point-of-care testing

  • Patient Empowerment: Enables self-monitoring, shared decision-making, and faster access to results, improving patient satisfaction and adherence to treatment plans for conditions like diabetes or anticoagulation therapy.

Indian Landscape - Local Lab Lifelines

  • Bridging healthcare gaps: Vital for timely diagnosis in rural/underserved areas, ↑access.
  • Govt. Push: National Health Mission (NHM), Ayushman Bharat (PM-JAY) promote POCD integration.
  • Indigenous Innovation: "Make in India" fosters affordable, robust, disease-specific POCDs.
    • Targets: Malaria, dengue, TB, HIV, anemia, glucose.
  • Operational Hurdles:
    • Quality control & standardization.
    • Supply chain, maintenance, waste management.
    • Training for ASHA/ANM workers.
  • Impact: Strengthens primary care, MCH, infectious disease surveillance, NCD screening. Point-of-Care Diagnostics in Rural India

⭐ The Indian Council of Medical Research (ICMR) is key in validating POC diagnostic kits for the Indian context.

High‑Yield Points - ⚡ Biggest Takeaways

Error: Failed to generate content for this concept group.

Practice Questions: Point-of-Care Diagnostics

Test your understanding with these related questions

Which of the following attributes are essential for an ideal screening test?

1 of 5

Flashcards: Point-of-Care Diagnostics

1/7

_____ is a sensitive non invasive test to detect hepatic fibrosis.

TAP TO REVEAL ANSWER

_____ is a sensitive non invasive test to detect hepatic fibrosis.

FibroTest

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial